Abstract:OBJECTIVE:To observe the effect of microRNA-155 (miR-155) on the inflammatory response of rat alveolar macrophages induced by lipopolysaccharide (LPS). METHODS:The alveolar macrophages NR8383 of rat were cultured in vitro, the macrophages in logarithmic growth phase were harvested to conduct experiment. (1) The 1 mg/L LPS was used to stimulate the rat alveolar macrophages for 3, 6, 12, and 24 hours, a phosphate buffer solution (PBS) control group was also set up. Enzyme linked immunosorbent assay (ELISA) was used to detect the dynamic changes of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in the supernatant, and real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR) was used to detect the dynamics expression of miR-155 in the cells, which confirmed the optimal time for LPS stimulation was 12 hours. (2) Carboxyfluorescein (FAM) labeled mimic (FAM mimic) and inhibitor (FAM inhibitor) were used to transfect the alveolar macrophage, and the transfection effect was observed under inverted fluorescence microscope 6 hours later to confirm the optimal transfection concentration of mimic was 20 nmol/L, and the optimal transfection concentration of inhibitor was 100 nmol/L. miR-155 mimic and miR-155 inhibitor were transfected to alveolar macrophages respectively at the optimal transfection concentration for 24 hours, and 1 mg/L LPS was used to stimulate the cells for 12 hours. A mimic negative control + LPS group and an inhibitor negative control + LPS group were set up. The expressions of IL-1β and TNF-α in the supernatant were determined by ELISA to observe the regulation of miR-155 on inflammatory response of alveolar macrophages. RESULTS:(1) After stimulation of 1 mg/L LPS on alveolar macrophages, the contents of IL-1β and TNF-α in the supernatant and the expression of miR-155 in the cells were increased gradually with time prolongation, IL-1β and TNF-α contents peaked at 12 hours, and the expression of miR-155 peaked at 24 hours [as compared with PBS control group, IL-1β (ng/L): 910.43±36.09 vs. 22.66±7.84, TNF-α (ng/L): 3 138.39±394.10 vs. 233.92±8.84, miR-155 (2-ΔΔCt): 7.82±0.30 vs. 1, all P < 0.05]. (2) Under inverted fluorescence microscope, after 20 nmol/L FAM mimic or 100 nmol/L FAM inhibitor transfected alveolar macrophages for 6 hours, a large number of cells showed green fluorescence, indicating that the transfection was successful. The expression of miR-155 in the cells transfected with 20 nmol/L miR-155 mimic was up-regulated by (236.73±46.49) times as much as that in the negative control group (P < 0.05), and the levels of IL-1β and TNF-α in the supernatant of the cells stimulated by 1 mg/L LPS for 12 hours were significantly lower than those in the negative control group [IL-1β (ng/L): 324.37±36.59 vs. 799.31±39.44, TNF-α (ng/L): 1 554.01±342.48 vs. 3 020.49±418.30, both P < 0.05]. The miR-155 activity was significantly inhibited in the cells transfected with 100 nmol/L miR-155 inhibitor, and the expression of miR-155 was decreased by (4.00±3.26)% as compared with the negative control group, but the difference was not statistically significant (P > 0.05), and the levels of IL-1β and TNF-α in the supernatant of the cells stimulated by 1 mg/L LPS for 12 hours were significantly higher than those in the negative control group [IL-1β (ng/L): 1 358.98±212.04 vs. 878.68±53.42, TNF-α (ng/L): 4 225.57±281.11 vs. 2 881.32±286.08, both P < 0.05]. CONCLUSIONS:In LPS induced inflammatory response of alveolar macrophages, miR-155 plays an obvious inhibitory role.

[Protective Effect of Microrna-155 Antisense Oligonucleotid on Lipopolysaccharide-Induced Acute Lung Injury in Mice].

Antisense Oligonucleotide Treatment Enhances The Recovery Of Acute Lung Injury Through Il-10-Secreting M2-Like Macrophage-Induced Expansion Of Cd4(+) Regulatory T Cells

[Effects of Microrna-155 on Mice with Lipopolysaccharide-Induced Acute Lung Injury].

Effect of microRNA-155 agonist on inflammatory response during liver injury in septic mice

[Protective Effect Against Monoammonium Glycyrrhizinate on Lipopolysaccharide-Induced Acute Lung Injury in Mice].

Effects of microRNA-155 inhibitor on JAK/STAT1 signaling pathway in lipopolysaccharide-induced lung injury

Macrophage Micro-Rna-155 Promotes Lipopolysaccharide-Induced Acute Lung Injury in Mice and Rats

Mir‐146b Overexpression Ameliorates Lipopolysaccharide‐induced Acute Lung Injury in Vivo and in Vitro

Standardized Myrtol Attenuates Lipopolysaccharide Induced Acute Lung Injury in Mice

Plantamajoside Ameliorates Lipopolysaccharide-Induced Acute Lung Injury Via Suppressing NF-κB and MAPK Activation.

Lactobacillus Reuteri Ameliorates Lipopolysaccharide-Induced Acute Lung Injury by Modulating the Gut Microbiota in Mice.

A Microsatellite DNA-derived Oligodeoxynucleotide Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting the HMGB1-TLR4-NF-κB Signaling Pathway

Expression Pattern Changes of Microrna in the Lung Tissue of Mice with Acute Lung Injury Induced by Lipopolysaccharide

[Microrna-155 Reduces Inflammatory Response Induced by Lipopolysaccharide in Alveolar Macrophages].

Effect of Allicin on Mice with Acute Lung Injury Induced by Lipopolysaccharide

Effects of microRNA-155 on interleukin-1 receptor-associated kinase 1 and 4 mRNA expression in liver injury of endotoximia mice

MicroRNA-9-5p Is Involved in Lipopolysaccharide-Induced Acute Lung Injury Via the Regulation of Macrophage Polarization

Inhibition of miR-221 alleviates LPS-induced acute lung injury via inactivation of SOCS1/NF-κB signaling pathway.

The function and mechanism of microRNA-92a-3p in lipopolysaccharide-induced acute lung injury

MiR-146a alleviates acute lung injury via inhibiting Notch 1 signaling pathway targeting macrophage

Protective effects of resveratrol on acute lung injury induced by lipopolysaccharide in mices